Dynamics in Post-pandemic Global Hereditary Cancer Testing Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ647506 No. of Pages: 127 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Hereditary Cancer Testing market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Hereditary Cancer Testing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category RNA Testing DNA Testing Segmented by End User/Segment Breast Cancer Gastrointestinal Cancer Prostate Cancer Respiratory/Lung Cancer Other Cancers Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Strand Life Sciences Quest Diagnostics Progenity，Inc Pathway Genomics NeoGenomics Natera Myriad Genetics Myogenes LabSolutions LabCorp Fulgent Genetics CellMax Life Caris Life Sciences Blueprint Genetics BioReference Laboratories (GeneDx) Asper Biogene ARUP Laboratories Ambry Genetics (Konica Minota)
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Hereditary Cancer Testing Market Status and Forecast (2016-2027)
1.3.2 Global Hereditary Cancer Testing Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Hereditary Cancer Testing Supply by Company
2.1 Global Hereditary Cancer Testing Sales Value by Company
2.2 Hereditary Cancer Testing Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Hereditary Cancer Testing Market Status by Category
3.1 Hereditary Cancer Testing Category Introduction
3.1.1 RNA Testing
3.1.2 DNA Testing
3.2 Global Hereditary Cancer Testing Market by Category
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional Hereditary Cancer Testing Market Status by End User/Segment
4.1 Hereditary Cancer Testing Segment by End User/Segment
4.1.1 Breast Cancer
4.1.2 Gastrointestinal Cancer
4.1.3 Prostate Cancer
4.1.4 Respiratory/Lung Cancer
4.1.5 Other Cancers
4.2 Global Hereditary Cancer Testing Market by End User/Segment
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global Hereditary Cancer Testing Market Status by Region
5.1 Global Hereditary Cancer Testing Market by Region
5.2 North America Hereditary Cancer Testing Market Status
5.3 Europe Hereditary Cancer Testing Market Status
5.4 Asia Pacific Hereditary Cancer Testing Market Status
5.5 Central & South America Hereditary Cancer Testing Market Status
5.6 Middle East & Africa Hereditary Cancer Testing Market Status
6 North America Hereditary Cancer Testing Market Status
6.1 North America Hereditary Cancer Testing Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Hereditary Cancer Testing Market Status
7.1 Europe Hereditary Cancer Testing Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Hereditary Cancer Testing Market Status
8.1 Asia Pacific Hereditary Cancer Testing Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Hereditary Cancer Testing Market Status
9.1 Central & South America Hereditary Cancer Testing Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Hereditary Cancer Testing Market Status
10.1 Middle East & Africa Hereditary Cancer Testing Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Hereditary Cancer Testing Market Forecast by Category and by End User/Segment
12.1 Global Hereditary Cancer Testing Sales Value Forecast (2022-2027)
12.2 Global Hereditary Cancer Testing Forecast by Category
12.3 Global Hereditary Cancer Testing Forecast by End User/Segment
13 Global Hereditary Cancer Testing Market Forecast by Region/Country
13.1 Global Hereditary Cancer Testing Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Strand Life Sciences
14.1.1 Company Information
14.1.2 Hereditary Cancer Testing Product Introduction
14.1.3 Strand Life Sciences
Hereditary Cancer Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Quest Diagnostics
14.2.1 Company Information
14.2.2 Hereditary Cancer Testing Product Introduction
14.2.3 Quest Diagnostics
Hereditary Cancer Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Progenity，Inc
14.3.1 Company Information
14.3.2 Hereditary Cancer Testing Product Introduction
14.3.3 Progenity，Inc
Hereditary Cancer Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Pathway Genomics
14.4.1 Company Information
14.4.2 Hereditary Cancer Testing Product Introduction
14.4.3 Pathway Genomics
Hereditary Cancer Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 NeoGenomics
14.5.1 Company Information
14.5.2 Hereditary Cancer Testing Product Introduction
14.5.3 NeoGenomics
Hereditary Cancer Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Natera
14.6.1 Company Information
14.6.2 Hereditary Cancer Testing Product Introduction
14.6.3 Natera
Hereditary Cancer Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Myriad Genetics
14.7.1 Company Information
14.7.2 Hereditary Cancer Testing Product Introduction
14.7.3 Myriad Genetics
Hereditary Cancer Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Myogenes
14.8.1 Company Information
14.8.2 Hereditary Cancer Testing Product Introduction
14.8.3 Myogenes
Hereditary Cancer Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 LabSolutions
14.9.1 Company Information
14.9.2 Hereditary Cancer Testing Product Introduction
14.9.3 LabSolutions
Hereditary Cancer Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 LabCorp
14.10.1 Company Information
14.10.2 Hereditary Cancer Testing Product Introduction
14.10.3 LabCorp
Hereditary Cancer Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 Fulgent Genetics
14.12 CellMax Life
14.13 Caris Life Sciences
14.14 Blueprint Genetics
14.15 BioReference Laboratories (GeneDx)
14.16 Asper Biogene
14.17 ARUP Laboratories
14.18 Ambry Genetics (Konica Minota)
15 Conclusion
16 Methodology
List of Tables and Figures
Ask Sample Report to get more details… NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com